We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
AUM
$10.5B
AUM Growth
+$6.2B
Cap. Flow
+$4.78B
Cap. Flow %
45.54%
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 7.01%
2 Healthcare 6.25%
3 Communication Services 2.7%
4 Consumer Discretionary 2.07%
5 Financials 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTT
951
CALL
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
-50,000
Closed -$1.09M
ATNX
952
DELISTED
Athenex, Inc. Common Stock
ATNX
-2,698
Closed -$653K
BIOR
953
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
-160
Closed -$361K
ETTX
954
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
-579,379
Closed -$1.18M
CALA
955
DELISTED
Calithera Biosciences, Inc
CALA
-3,794
Closed -$333K
CMPI
956
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
-44,966
Closed -$518K
ZSAN
957
DELISTED
Zosano Pharma Corporation
ZSAN
-12,948
Closed -$734K
FRTA
958
DELISTED
Forterra, Inc
FRTA
-379,987
Closed -$4.49M
PPD
959
DELISTED
PPD, Inc. Common Stock
PPD
-138,824
Closed -$5.13M
HZAC.U
960
DELISTED
Horizon Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third o
HZAC.U
-1,250,000
Closed -$13M
QELLU
961
DELISTED
Qell Acquisition Corp. Unit
QELLU
-200,000
Closed -$2.03M
SNPR.U
962
DELISTED
Tortoise Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of
SNPR.U
-150,000
Closed -$1.63M
PDAC.U
963
DELISTED
Peridot Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one
PDAC.U
-125,000
Closed -$1.25M
RTP.U
964
DELISTED
Reinvent Technology Partners Units, each consisting of one Class A ordinary share and one-fourth of
RTP.U
-100,000
Closed -$1.15M
CLII.U
965
DELISTED
Climate Change Crisis Real Impact I Acquisition Corporation Units, each consisting of one share of C
CLII.U
-50,000
Closed -$503K
FIIIU
966
DELISTED
Forum Merger III Corporation Units
FIIIU
-50,000
Closed -$522K
ACTCU
967
DELISTED
ArcLight Clean Transition Corp. Unit
ACTCU
-75,000
Closed -$753K
VSPRU
968
DELISTED
Vesper Healthcare Acquisition Corp. Unit
VSPRU
-250,000
Closed -$2.56M
STPK.U
969
DELISTED
Star Peak Energy Transition Corp. Units, each consisting of one share of Class A common stock, and o
STPK.U
-875,000
Closed -$8.97M
DMYD.U
970
DELISTED
dMY Technology Group, Inc. II Units, each consisting of one share of Class A common stock and one-th
DMYD.U
-150,000
Closed -$1.53M
HMSY
971
DELISTED
HMS Holdings Corp.
HMSY
-95,660
Closed -$2.29M
BFT.U
972
DELISTED
Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an
BFT.U
-3,000,000
Closed -$30.6M
PRVL
973
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
-17,200
Closed -$175K
TCO
974
CALL
DELISTED
Taubman Centers Inc.
TCO
-120,000
Closed -$4M
UFS
975
DELISTED
DOMTAR CORPORATION (New)
UFS
-148,602
Closed -$4.23M

Similar funds

CAAS Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.

  • CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
  • CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
  • CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
  • CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
  • CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
  • CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
  • CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.

Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.